The European Cardiovascular Monitor (ECVM) measures clinical practice within the European cardiovascular market. We produce market reports in a quarterly format through the use of a panel of approximately 230 centres across Western Europe and 120 in Central and Eastern Europe.
Clients use the monitor to obtain key market, customer and sales information when they need it. Through an ECVM subscription clients can:
- Percutaneous coronary interventions (PCI)
- Measure the number percutaneous coronary interventions (PCI) taking place across Europe on a country basis.
- Track drug eluting stent (DES) penetration rates based on consumption across Europe.
- Measure the use of other coronary intervention-related devices such as balloons, guide-wires, guiding catheters, embolic protection devices.
- Measure consumption/device usage and see accurate market share information for each leading brand.
- Track device average selling prices (ASPs) on a quarterly basis.
- Cardiac Surgey (CS)
- Measure the mechanical valves and biological valves used in Western Europe.
- This also includes new fast growing techniques such as the Transcatheter Heart Valve replacement.
- Measure consumption/device usage and see accurate market share information for each leading brand.
- Track device average selling prices (ASPs) on a quarterly basis.
- Transcatheter Heart Valve (TAVR)
- Measure the number of transcatheter heart valve procedures in Western Europe.
- Measure the usage of transcatheter heart valves, with particular reference to valve size and device manufacturers.
- Track device average selling prices (ASPs) on a quarterly basis.
Formats
All ECVM reports are available in the following formats:
- In depth quarterly and historical analysis;
- European Summary (compact version for country managers);
- Executive Summary (quarterly overview);
- Database/pivot table format
- Ad-hoc documents upon request
The ECVM methodology
The ECVM methodology consists of a consumption-based panel formed of Physicians from over 230 hospitals across Europe. All the hospitals are medium and high-volume centres.
Data is received on a quarterly basis from Panel members and represents the whole hospital. Data is gathered through questionnaires specifically designed, through ongoing telephone interviews and 1-to-1 meetings at conferences.
Data from the Panel show changes in clinical practices and are a reliable indication of the most used technologies. However, in order to determine exact market share and turnover figures, our analysis model takes in account 11 other factors. These factors are (in alphabetical order):
- Brand reputation
- CE approval - National guidelines & protocols - reimbursement policies
- Corporate financial results
- Innovation/Product launch
- Marketing campaigns
- Media impact
- Portfolio
- Pricing
- Product penetration rate
- Sales force
- Trends
The final data are cross-referenced with public registries and with sales figures from industry partners.
The composition of our research Panel is stable: this allows us to appreciate changes in clinical practice, as well as in the use of technologies over a certain period of time.
Market demographic coverage
The European Cardiovascular Monitor covers 14 EU States (Austria, Belgium & Luxemburg, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, UK (including Republic of Ireland), plus Switzerland. The service is extended in the Eastern European countries to Belarus, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Israel, Latvia, Lithuania, Macedonia, Poland, Romania, Russian Federation, Serbia/Montenegro, Slovakia, Slovenia and Ukraine.
For further information about the report, clients quoting and real data samples, please click here
